-
digital.ahrq.gov/sites/default/files/docs/AHRQ_Webinar_Aug_2009_Med_Mgmt.pdf
January 01, 2009 - Qualitative data from outpatient setting
– Review of medication history, identifying
patients on high-risk drugs … EPCS
• Pharmaceutical (or drug) diversion is the
channeling of licit controlled substances or
other pharmaceuticals … prescriptions; doctor shopping;
indiscriminate prescribing; and illegal sales
of prescriptions and pharmaceuticals … potential benefits unique to
EPCS:
• Reductions in non-medical use and abuse
of federally controlled pharmaceuticals … catchment Systems catchment
areaarea
• Obtain DEA waiver to allow e-prescribing of
Schedule II-V drugs
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015280-hsu-final-report-2008.pdf
January 01, 2008 - Among diabetic patients receiving diabetes drugs in 2004, 87.6% had ≥
1 HbA1c test during the year and … Among those with a
HbA1c test in 2004: 10.6% did not receive any drugs in the 90 days before their test … Additionally, 50.5% received
drugs in one, 30.7% in two, and 8.3% in three or more classes of diabetes … drugs. … Among subjects on any regimen, the mean proportion of days
covered by any lipid drugs was 90.8%; among
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/rotich-jk-et-al-2003
January 01, 2003 - The authors present a summary of the clinics visited, diagnoses made, drugs prescribed, and tests performed
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015175-weissman-final-report-2007.pdf
January 01, 2007 - the new technology increase their use of generic drug equivalents,
prescribe a higher proportion of drugs … found on the formulary, and decrease the cost of
drugs per prescription? … Since we have only data on drugs that were dispensed, we can only evaluate potential
DDIs, we cannot … determine whether actual events occurred or whether patients were
actually taking the two drugs at … The proportion of drugs in Tier 2 and Tier 3 (brand medications)
decreased correspondingly.
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/annual-summary/2011
January 01, 2011 - initiative to conduct research and provide education that advances the optimal use of therapeutics (i.e., drugs
-
digital.ahrq.gov/sites/default/files/docs/publication/AppendixA_Comm_Tech_For_AA_Women.pdf
February 01, 2010 - ever been paid for sex, or had sex for drugs? … (street
drugs)? … Yes At risk for STI
Plug in "have used
street drugs." … (street drugs)? … intravenous (IV) drugs?
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/cds-drug-drug-interactions
January 01, 2023 - Clinical decision support for drug-drug interactions: improvement needed.
Citation
Horn JR, Gumpper KF, Hardy JC, et al. Clinical decision support for drug-drug interactions: improvement needed. Am J Health Syst Pharm 2013 May 15;70(10):905-9.
Link
http://www.ncbi.nlm.nih.gov/pubmed/23640353
…
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/national
January 01, 2023 - National rules for drug-drug interactions: are they appropriate for tertiary hospitals?
Citation
Cho I, Lee JH, Choi J, et al. National rules for drug-drug interactions: are they appropriate for tertiary hospitals? J Korean Med Sci 2016 Dec;31(12):1887-96. PMID: 27822925.
Link
https://www.ncbi…
-
digital.ahrq.gov/program-overview/research-stories/creating-meaningful-decision-support-reduce-drug-drug
January 01, 2023 - Creating Meaningful Decision Support to Reduce Drug-Drug Interactions
Theme:
Optimizing Care Delivery for Clinicians
Subtheme:
Optimizing Patient Safety Using Digital Healthcare Solutions
By individualizing drug–drug interaction alerts to individual patient circumstances, providers can …
-
digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/improving
January 01, 2023 - Improving the specificity of drug-drug interaction alerts: Can it be done?
Citation
Reese T, Wright A, Liu S, Boyce R, Romero A, Del Fiol G, Kawamoto K, Malone D. Improving the specificity of drug-drug interaction alerts: Can it be done? Am J Health Syst Pharm. 2022 Jun 23;79(13):1086-1095. doi: 10.10…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026544-devine-final-report-2022.pdf
January 01, 2022 - Pharmacogenomics Implementation Consortium (CPIC) has published 25 guidelines
for 20 pharmacogenes and 61 drugs … were modeled separately, and thus the
same patient would not trigger multiple alerts for multiple drugs … Incorporation of alerts fired
for refills and the possibility that the same patient may require multiple drugs … beyond the scope for the current application development, including: the
addition of more genes and drugs … were commonly dispensed in practice.5This
evidence suggests that incorporating a broad list of genes, drugs
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/crosson-jc
January 01, 2023 - program and thought this could undermine their clinical authority as they prefer to write for brand name drugs
-
digital.ahrq.gov/program-overview/research-stories/virtual-pharmacy-improves-medication-use-and-patient-safety-palliative-care
January 01, 2023 - illness, the natural aging process, and multiple-drug treatment—affect their ability to metabolize drugs
-
digital.ahrq.gov/sites/default/files/docs/resource/Wolf_Q6_Med_List_1_27_09.pdf
June 16, 2021 - This includes
prescription drugs, over-the-counter medicines, vitamins, and other supplements.
-
digital.ahrq.gov/standards-0
January 01, 2023 - The FDA maintains the National Drug Code (NDC) Directory, the universal set of all drugs manufactured … The study found that SPL labels currently contain only a fraction of RxNorm clinical drugs, but they
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-9
January 01, 2023 - High-priority drug-drug interactions for use in electronic health records.
Citation
Phansalkar S, Desai AA, Bell D, et al. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc 2012 Sep 1;19(5):735-43.
Link
Phansalkar S, Desai AA, Bell D, et al. High…
-
digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/barriers
January 01, 2023 - Barriers to adoption of tailored drug-drug interaction clinical decision support.
Citation
Zhang T, Gephart SM, Subbian V, Boyce RD, Villa-Zapata L, Tan MS, Horn J, Gomez-Lumbreras A, Romero AV, Malone DC. Barriers to adoption of tailored drug-drug interaction clinical decision support. Appl Clin Info…
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/annual-summary/2012
January 01, 2012 - Patient Reports of Side Effects with Electronic Health Records for Surveillance of Recently Approved Drugs … project was to increase surveillance evidence for recently-released Food and Drug Administration-approved drugs
-
digital.ahrq.gov/sites/default/files/docs/citation/u18hs027099-malone-final-report-2022.pdf
January 01, 2022 - associated with gastrointestinal bleeding for
patients taking warfarin and non-steroidal anti-inflammatory drugs … decision making, drug-drug interactions, SMART on FHIR, warfarin, non-steroidal anti-
inflammatory drugs … Interactions: Design and Usability of an Application for
Warfarin and Non-steroidal Anti-inflammatory Drugs … Interactions: Design and Usability of an Application for
Warfarin and Non-steroidal Anti-inflammatory Drugs … Reduce Harm From Drug-Drug
Interactions: Case Study of Warfarin and Non-Steroidal Anti-Inflammatory Drugs
-
digital.ahrq.gov/ahrq-funded-projects/identifying-sepsis-phenotypes-associated-antibiotic-resistant-pathogens-using
January 01, 2025 - helping doctors select the most appropriate antibiotics, reducing unnecessary use of broad-spectrum drugs